Insider Shareholders with Direct Ownership of Dia Medica Therapeutics Inc. (DMAC)
This section provides a comprehensive overview of the insiders with direct ownership of Dia Medica Therapeutics Inc. (DMAC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
DiaMedica Therapeutics Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
David J. Wambeke
Chief Business Officer |
527,114 | 0 | 527,114 $2.36 Million | 3 |
Nov 16, 2023
Added 3.66%
|
|
Randall Michael Giuffre
Director |
306,793 | 15,000 | 364,551 $1.63 Million | 14 |
Jan 02, 2024
Added 5.0%
|
|
Richard D. Pilnik
Director |
217,756 | 0 | 278,602 $1.25 Million | 8 |
Jan 02, 2024
Added 9.83%
|
|
Amy L. Burroughs
Director |
73,288 | 0 | 73,288 $328,330 | 3 |
Jan 03, 2023
Added 18.97%
|
|
Dietrich John Pauls
President and CEO |
37,787 | 0 | 68,591 $307,287 | 3 |
Jun 23, 2023
Added 15.71%
|
|
James T. Parsons
Director |
45,946 | 0 | 59,937 $268,517 | 3 |
Jan 02, 2024
Added 26.34%
|
|
Harry W Alcorn Jr
SVP, Clinical Operations |
35,322 | 0 | 43,582 $195,247 | 2 |
Sep 15, 2021
Added 25.61%
|
|
Charles Pauling Semba
Director |
39,318 | 0 | 39,318 $176,144 | 3 |
Jan 02, 2024
Added 19.25%
|
|
Scott Kellen
CFO and Secretary |
22,000 | 0 | 32,290 $144,659 | 3 |
Jun 23, 2023
Added 23.65%
|
|
Richard Kuntz
Director |
14,285 | 0 | 14,285 $63,996 | 1 |
Jan 02, 2024
Added 50.0%
|